Trovato M, Sartorius R, D’Apice L, Manco R, De Berardinis P. Viral rising ailments: challenges in creating vaccination methods. Entrance Immunol. 2020;11:2130.
Adhikari S, Adhikari U, Mishra A, Guragain BS. Nanomaterials for diagnostic, remedy and prevention of COVID-19. Appl Sci Technol Ann. 2020;1:155–64.
Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, et al. Medical, laboratory and imaging options of COVID-19: a scientific evaluate and meta-analysis. Journey Med Infect Dis. 2020;34: 101623.
Yang G, Chen S, Zhang J. Bioinspired and biomimetic nanotherapies for the remedy of infectious ailments. Entrance Pharmacol. 2019;10:751.
Tang Z, Zhang X, Shu Y, Guo M, Zhang H, Tao W. Insights from nanotechnology in COVID-19 remedy. Nano Right this moment. 2021;36: 101019.
Chauhan G, Madou MJ, Kalra S, Chopra V, Ghosh D, Martinez-Chapa SO. Nanotechnology for COVID-19: therapeutics and vaccine analysis. ACS Nano. 2020;14:7760–82.
van Riel D, de Wit E. Subsequent-generation vaccine platforms for COVID-19. Nat Mater. 2020;19:810–2.
Draz MS, Shafiee H. Functions of gold nanoparticles in virus detection. Theranostics. 2018;8:1985.
Paull JRA, Heery GP, Bobardt MD, Castellarnau A, Luscombe CA, Fairley JK, et al. Virucidal and antiviral exercise of astodrimer sodium in opposition to SARS-CoV-2 in vitro. Antivir Res. 2021;191: 105089.
Zhang Z, Zhao J, Chen Z, Wu H, Wang S. A molybdenum-based nanoplatform with multienzyme mimicking capacities for oxidative stress-induced acute liver damage remedy. Inorg Chem Entrance. 2023;10:1305–14.
Aasi A, Aghaei SM, Panchapakesan B. A density useful principle examine on the interplay of toluene with transition metallic adorned carbon nanotubes: a promising platform for early detection of lung most cancers from human breath. Nanotechnology. 2020;31: 415707.
Qian Okay, Wang Y, Hua L, Chen A, Zhang Y. New methodology of lung most cancers detection by saliva check utilizing surface-enhanced Raman spectroscopy. Thorac Most cancers. 2018;9:1556–61.
Yao H, Zhang N, Zhang R, Duan M, Xie T, Pan J, et al. Severity detection for the coronavirus illness 2019 (COVID-19) sufferers utilizing a machine studying mannequin primarily based on the blood and urine checks. medRxiv. 2020. https://doi.org/10.3389/fcell.2020.00683.
Yang X, Wang S, Zhang X, Ye C, Wang S, An X. Growth of PVA-based microsphere as a possible embolization agent. Biomater Adv. 2022;135: 112677.
Arifin NFT, Yusof N, Nordin NAHM, Jaafar J, Ismail AF, Aziz F, et al. Potential software of biomass derived graphene for COVID-19 pandemic. Mater Right this moment Proc. 2021;46:1959–62.
Zhang B, Salieb-Beugelaar GB, Nigo MM, Weidmann M, Hunziker P. Diagnosing dengue virus an infection: fast checks and the function of micro/nanotechnologies. Nanomed Nanotechnol Biol Med. 2015;11:1745–61.
Maduray Okay, Parboosing R. Steel nanoparticles: a promising remedy for viral and arboviral infections. Biol Hint Elem Res. 2020;199(8):3159–76.
Medhi R, Srinoi P, Ngo N, Tran HV, Lee TR. Nanoparticle-based methods to fight COVID-19. ACS Appl Nano Mater. 2020;3:8557–80.
Pung R, Chiew CJ, Younger BE, Chin S, Chen MIC, Clapham HE, et al. Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures. Lancet. 2020;395:1039–46.
Cappellano G, Abreu H, Casale C, Dianzani U, Chiocchetti A. Nano-microparticle platforms in creating next-generation. Vaccines. 2021;9:1–18.
Rosi NL, Mirkin CA. Nanostructures in biodiagnostics. Chem Rev. 2005;105(4):1547–62.
Pramanik A, Gao Y, Patibandla S, Mitra D, McCandless MG, Fassero LA, et al. The fast prognosis and efficient inhibition of coronavirus utilizing spike antibody hooked up gold nanoparticles. Nanoscale Adv. 2021;3:1588–96.
Moitra P, Alafeef M, Alafeef M, Alafeef M, Dighe Okay, Frieman MB, et al. Selective naked-eye detection of SARS-CoV-2 mediated by N gene focused antisense oligonucleotide capped plasmonic nanoparticles. ACS Nano. 2020;14:7617–27.
Jeremiah SS, Miyakawa Okay, Morita T, Yamaoka Y, Ryo A. Potent antiviral impact of silver nanoparticles on SARS-CoV-2. Biochem Biophys Res Commun. 2020;533:195–200.
Pilaquinga F, Morey J, Torres M, Seqqat R, Piña MDLN. Silver nanoparticles as a possible remedy in opposition to SARS-CoV-2: a evaluate. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021;13:1–19.
Thorlund Okay, Awad T, Boivin G, Thabane L. Systematic evaluate of influenza resistance to the neuraminidase inhibitors. BMC Infect Dis. 2011;11:1–13.
Damage AC, Ho H-T, Barr I. Resistance to anti-influenza medication: adamantanes and neuraminidase inhibitors. Knowledgeable Rev Anti Infect Ther. 2006;4:795–805.
van der Vries E, Stelma FF, Boucher CAB. Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus. N Engl J Med. 2010;363:1381–2.
Meng J, Stobart CC, Hotard AL, Moore ML. An outline of respiratory syncytial virus. PLoS Pathog. 2014;10: e1004016.
Efstathiou C, Abidi SH, Harker J, Stevenson NJ. Revisiting respiratory syncytial virus’s interplay with host immunity, in the direction of novel therapeutics. Cell Mol Life Sci. 2020;77:1–14.
Trus I, Udenze D, Berube N, Wheler C, Martel M-J, Gerdts V, et al. CpG-recoding in Zika virus genome causes host-age-dependent attenuation of an infection with safety in opposition to deadly heterologous problem in mice. Entrance Immunol. 2020;10:3077.
Zhu Z, Lian X, Su X, Wu W, Marraro GA, Zeng Y. From SARS and MERS to COVID-19: a short abstract and comparability of extreme acute respiratory infections attributable to three extremely pathogenic human coronaviruses. Respir Res. 2020;21:1–14.
Fung SY, Yuen KS, Ye ZW, Chan CP, Jin DY. A tug-of-war between extreme acute respiratory syndrome coronavirus 2 and host antiviral defence: classes from different pathogenic viruses. Emerg Microbes Infect. 2020;9:558–70.
Zumla A, Chan JFW, Azhar EI, Hui DSC, Yuen KY. Coronaviruses-drug discovery and therapeutic choices. Nat Rev Drug Discov. 2016;15:327–47.
Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, et al. Coronavirus infections and immune responses. J Med Virol. 2020;92:424–32.
Lim Y, Ng Y, Tam J, Liu D. Human coronaviruses: a evaluate of virus–host interactions. Illnesses. 2016;4:26.
Abdelrahman Z, Li M, Wang X. Comparative evaluate of SARS-CoV-2, SARS-CoV, MERS-CoV, and influenza a respiratory viruses. Entrance Immunol. 2020;11:2309.
Tang T, Bidon M, Jaimes JA, Whittaker GR, Daniel S. Coronavirus membrane fusion mechanism gives a possible goal for antiviral growth. Antivir Res. 2020;178: 104792.
Huang Y, Yang C, Xu X, Xu W, Liu S. Structural and useful properties of SARS-CoV-2 spike protein: potential antivirus drug growth for COVID-19. Acta Pharmacol Sin. 2020;41:1141–9.
Cui J, Li F, Shi Z-L. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17:181–92.
Cantuti-Castelvetri L, Ojha R, Pedro LD, Djannatian M, Franz J, Kuivanen S, et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science (80-). 2020;370:856–60.
Wang Okay, Chen W, Zhang Z, Deng Y, Lian JQ, Du P, et al. CD147-spike protein is a novel route for SARS-CoV-2 an infection to host cells. Sign Transduct Goal Ther. 2020;5:1–10.
Sigrist CJA, Bridge A, Le Mercier P. A possible function for integrins in host cell entry by SARS-CoV-2. Antivir Res. 2020;177: 104759.
Ortiz ME, Thurman A, Pezzulo AA, Leidinger MR, Klesney-Tait JA, Karp PH, et al. Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 within the human respiratory tract. EBioMedicine. 2020;60: 102976.
Zumla A, Hui DS, Perlman S. Center East respiratory syndrome. Lancet. 2015;386:995–1007.
Kleine-Weber H, Elzayat MT, Hoffmann M, Pöhlmann S. Purposeful evaluation of potential cleavage websites within the MERS-coronavirus spike protein. Sci Rep. 2018;8:1–11.
Millet JK, Whittaker GR. Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells. Virology. 2018;517:3–8.
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry will depend on ACE2 and TMPRSS2 and is blocked by a clinically confirmed protease inhibitor. Cell. 2020;181:271–80.
Hoffmann M, Kleine-Weber H, Pöhlmann S. A multibasic cleavage website within the spike protein of SARS-CoV-2 is important for an infection of human lung cells. Mol Cell. 2020;78:779–84.
Shang J, Wan Y, Luo C, Ye G, Geng Q, Auerbach A, et al. Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci. 2020;117:11727–34.
Dittmayer C, Meinhardt J, Radbruch H, Radke J, Heppner BI, Heppner FL, et al. Why misinterpretation of electron micrographs in SARS-CoV-2-infected tissue goes viral. Lancet. 2020;396:e64–5.
V’kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol. 2021;19:155–70.
Kasuga Y, Zhu B, Jang Okay-J, Yoo J-S. Innate immune sensing of coronavirus and viral evasion methods. Exp Mol Med. 2021;53:723–36.
Lee S, Channappanavar R, Kanneganti T-D. Coronaviruses: innate immunity, inflammasome activation, inflammatory cell loss of life, and cytokines. Tendencies Immunol. 2020;41(12):1083–99.
Sette A, Crotty S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell. 2021;184(4):861–80.
de Rivero Vaccari JC, Dietrich WD, Keane RW, de Rivero Vaccari JP. The inflammasome in occasions of COVID-19. Entrance Immunol. 2020;11:2474.
Harvey WT, Carabelli AM, Jackson B, Gupta RK, Thomson EC, Harrison EM, et al. SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol. 2021;19(7):409–24.
Kim S, Lei Z, Dicker J, Cao Y, Zhang XF, Im W. Differential interactions between human ACE2 and spike RBD of SARS-CoV-2 variants of concern. bioRxiv Prepr. Serv Biol. 2021;453598.
Saito A, Nasser H, Uriu Okay, Kosugi Y, Irie T, Shirakawa Okay, et al. SARS-CoV-2 spike P681R mutation enhances and accelerates viral fusion. bioRxiv. 2021. https://doi.org/10.1101/2021.06.17.448820.
Zhang J, Xiao T, Cai Y, Lavine CL, Peng H, Zhu H, et al. Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant. bioRxiv. 2021. https://doi.org/10.1101/2021.08.17.456689.
Planas D, Veyer D, Baidaliuk A, Staropoli I, Guivel-Benhassine F, Rajah MM, et al. Lowered sensitivity of SARS-CoV-2 variant Delta to antibody neutralization. Nature. 2021;596(7871):276–80.
Saito A, Kimura I, Yamasoba D, Gerber PP. Altered TMPRSS2 utilization by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature. 2022;603:706–14.
Cele S, Jackson L, Khoury DS, Khan Okay, Moyo-Gwete T, Tegally H, et al. Omicron extensively however incompletely escapes Pfizer BNT162b2 neutralization. Nature. 2021;602:1–5.
Hui KPY, Ho JCW, Cheung M, Ng Okay, Ching RHH, Lai Okay, et al. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo. Nature. 2022;603:715–20.
Singhal T. The emergence of omicron: difficult occasions are right here once more! Indian J Pediatr. 2022;89:490–6.
Gralinski LE, Menachery VD. Return of the coronavirus: 2019-nCoV. Viruses. 2020;12:135.
Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal brokers. J Hosp Infect. 2020;104:246–51.
Cui L, Ren X, Wang J, Solar M. Synthesis of homogeneous carbon quantum dots by ultrafast dual-beam pulsed laser ablation for bioimaging. Mater Right this moment Nano. 2020;12: 100091.
Huang L, Gu M, Wang Z, Tang TW, Zhu Z, Yuan Y, et al. Extremely environment friendly and fast inactivation of coronavirus on non-metal hydrophobic laser-induced graphene in gentle situations. Adv Funct Mater. 2021;31:2101195.
Wang N, Ferhan AR, Yoon BK, Jackman JA, Cho N-J, Majima T. Chemical design rules of next-generation antiviral floor coatings. Chem Soc Rev. 2021;50:9741–65.
Hadidi M, Bigham A, Saebnoori E, Hassanzadeh-Tabrizi SA, Rahmati S, Alizadeh ZM, et al. Electrophoretic-deposited hydroxyapatite-copper nanocomposite as an antibacterial coating for biomedical functions. Surf Coat Technol. 2017;321:171–9.
Ansari M, Bigham A, Ahangar HA. Tremendous-paramagnetic nanostructured CuZnMg combined spinel ferrite for bone tissue regeneration. Mater Sci Eng C. 2019;105: 110084.
Bigham A, Aghajanian AH, Allahdaneh S, Hassanzadeh-Tabrizi SA. Multifunctional mesoporous magnetic Mg2SiO4–CuFe2O4 core–shell nanocomposite for simultaneous bone most cancers remedy and regeneration. Ceram Int. 2019;45:19481–21988.
Vincent M, Duval RE, Hartemann P, Engels-Deutsch M. Contact killing and antimicrobial properties of copper. J Appl Microbiol. 2018;124:1032–46.
Warnes SL, Little ZR, Keevil CW. Human coronavirus 229E stays infectious on frequent contact floor supplies. MBio. 2015;6:e01697-e1715.
Champagne V, Sundberg Okay, Helfritch D. Kinetically deposited copper antimicrobial surfaces. Coatings. 2019;9:257.
Behzadinasab S, Chin A, Hosseini M, Poon L, Ducker WA. A floor coating that quickly inactivates SARS-CoV-2. ACS Appl Mater Interfaces. 2020;12:34723–7. https://doi.org/10.1021/acsami.0c11425.
Das Jana I, Kumbhakar P, Banerjee S, Gowda CC, Kedia N, Kuila SK, et al. Copper nanoparticle-graphene composite-based clear floor coating with antiviral exercise in opposition to influenza virus. ACS Appl Nano Mater. 2020;4(1):352–62.
Liang L, Ahamed A, Ge L, Fu X, Lisak G. Advances in antiviral materials growth. ChemPlusChem. 2020;85:2105–28.
Salleh A, Naomi R, Utami ND, Mohammad AW, Mahmoudi E, Mustafa N, et al. The potential of silver nanoparticles for antiviral and antibacterial functions: a mechanism of motion. Nanomaterials. 2020;10:1566.
Balagna C, Perero S, Percivalle E, Nepita EV, Ferraris M. Virucidal impact in opposition to coronavirus SARS-CoV-2 of a silver nanocluster/silica composite sputtered coating. Open Ceram. 2020;1: 100006.
Bigham A, Foroughi F, Motamedi M, Rafienia M. Multifunctional nanoporous magnetic zinc silicate-ZnFe2O4 core-shell composite for bone tissue engineering functions. Ceram Int. 2018;44:11798–806.
Bigham A, Salehi AOM, Rafienia M, Salamat MR, Rahmati S, Raucci MG, et al. Zn-substituted Mg2SiO4 nanoparticles-incorporated PCL-silk fibroin composite scaffold: a multifunctional platform in the direction of bone tissue regeneration. Mater Sci Eng C. 2021;127: 112242.
Korant BD, Kauer JC, Butterworth BE. Zinc ions inhibit replication of rhinoviruses. Nature. 1974;248:588–90.
Learn SA, Obeid S, Ahlenstiel C, Ahlenstiel G. The function of zinc in antiviral immunity. Adv Nutr. 2019;10:696–710.
Ghaffari H, Tavakoli A, Moradi A, Tabarraei A, Bokharaei-Salim F, Zahmatkeshan M, et al. Inhibition of H1N1 influenza virus an infection by zinc oxide nanoparticles: one other rising software of nanomedicine. J Biomed Sci. 2019;26:1–10.
Hodek J, Zajícová V, Lovětinská-Šlamborová I, Stibor I, Müllerová J, Weber J. Protecting hybrid coating containing silver, copper and zinc cations efficient in opposition to human immunodeficiency virus and different enveloped viruses. BMC Microbiol. 2016;16:1–12.
El-Megharbel SM, Alsawat M, Al-Salmi FA, Hamza RZ. Using of (Zinc oxide nano-spray) for disinfection in opposition to “sars-cov-2” and testing its organic effectiveness on some biochemical parameters throughout (covid-19 pandemic)—“zno nanoparticles have antiviral exercise in opposition to (sars-cov-2).” Coatings. 2021;11:388.
Kim J, Lee SK, Lee J, Kim H, Kim NH, Lee CH, et al. ZnO nanowire-based early detection of SARS-CoV-2 antibody responses in asymptomatic sufferers with COVID-19. Adv Mater Interfaces. 2022;9:2102046.
Nunez FA, Castro ACH, de Oliveira VL, Lima AC, Oliveira JR, de Medeiros GX, et al. Electrochemical immunosensors primarily based on zinc oxide nanorods for detection of antibodies in opposition to SARS-CoV-2 spike protein in convalescent and vaccinated people. ACS Biomater Sci Eng. 2022;9:458–73.
Habibi-Yangjeh A, Asadzadeh-Khaneghah S, Feizpoor S, Rouhi A. Evaluation on heterogeneous photocatalytic disinfection of waterborne, airborne, and foodborne viruses: can we win in opposition to pathogenic viruses? J Colloid Interface Sci. 2020;580:503–14.
Dell’Edera M, Porto CL, De Pasquale I, Petronella F, Curri ML, Agostiano A, et al. Photocatalytic TiO2-based coatings for environmental functions. Catal Right this moment. 2021;380:62–83.
Moongraksathum B, Chien M-Y, Chen Y-W. Antiviral and antibacterial results of silver-doped TiO2 ready by the peroxo sol–gel methodology. J Nanosci Nanotechnol. 2019;19:7356–62.
Shakeri A, Yip D, Badv M, Imani SM, Sanjari M, Didar TF. Self-cleaning ceramic tiles produced through secure coating of TiO2 nanoparticles. Supplies (Basel). 2018;11:1003.
Nakano R, Hara M, Ishiguro H, Yao Y, Ochiai T, Nakata Okay, et al. Broad spectrum microbicidal exercise of photocatalysis by TiO2. Catalysts. 2013;3:310–23.
Rao G, Brastad KS, Zhang Q, Robinson R, He Z, Li Y. Enhanced disinfection of Escherichia coli and bacteriophage MS2 in water utilizing a copper and silver loaded titanium dioxide nanowire membrane. Entrance Environ Sci Eng. 2016;10:1–9.
Park GW, Cho M, Cates EL, Lee D, Oh B-T, Vinjé J, et al. Fluorinated TiO2 as an ambient light-activated virucidal floor coating materials for the management of human norovirus. J Photochem Photobiol B Biol. 2014;140:315–20.
Sinclair TR, Patil A, Raza BG, Reurink D, den Hengel SK, Rutjes SA, et al. Cationically modified membranes utilizing covalent layer-by-layer meeting for antiviral functions in ingesting water. J Membr Sci. 2019;570:494–503.
Klibanov AM. Completely microbicidal supplies coatings. J Mater Chem. 2007;17:2479–82.
Borrego JJ, Cornax R, Preston DR, Farrah SR, McElhaney B, Bitton G. Growth and software of latest positively charged filters for restoration of bacteriophages from water. Appl Environ Microbiol. 1991;57:1218–22.
Gao J, Solar S-P, Zhu W-P, Chung T-S. Chelating polymer modified P84 nanofiltration (NF) hole fiber membranes for prime environment friendly heavy metallic elimination. Water Res. 2014;63:252–61.
Tiliket G, Le SD, Moules V, Rosa-Calatrava M, Lina B, Valleton JM, et al. A brand new materials for airborne virus filtration. Chem Eng J. 2011;173:341–51.
Gelman F, Lewis Okay, Klibanov AM. Drastically reducing the titer of waterborne bacteriophage PRD1 by publicity to immobilized hydrophobic polycations. Biotechnol Lett. 2004;26:1695–700.
Haldar J, An D, de Cienfuegos LA, Chen J, Klibanov AM. Polymeric coatings that inactivate each influenza virus and pathogenic micro organism. Proc Natl Acad Sci. 2006;103:17667–71.
Pati R, Shevtsov M, Sonawane A. Nanoparticle vaccines in opposition to infectious ailments. Entrance Immunol. 2018;9:2224.
Dykman LA. Gold nanoparticles for preparation of antibodies and vaccines in opposition to infectious ailments. Knowledgeable Rev Vaccines. 2020;19:465–77.
Ma X, Zou F, Yu F, et al. Nanoparticle vaccines primarily based on the receptor binding area (RBD) and heptad repeat (HR) of SARS-CoV-2 elicit sturdy protecting immune responses. Immunity. 2020;53:1315–30.
Lamb YN. BNT162b2 mRNA COVID-19 vaccine: first approval. Rev Medication. 2021;81:495–501.
Wallace M, et al. The advisory committee on immunization practices’ interim suggestion to be used of Pfizer-BioNTech COVID-19 vaccine in adolescents aged 12–15 years—United States, Might 2021. Morb Mortal Wkly Rep. 2021;70:749–52.
Klimek L, Novak N, Hamelmann E, et al. Extreme allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Nice Britain and USA: place assertion of the German allergy societies: medical Affiliation of German Allergologists (AeDA), German Society for Allergology and Medical Immunology (DGAKI) and Society for Pediatric Allergology and Environmental Medication (GPA). Allergo J Int. 2021;30:51–5.
Hatziantoniou S, Maltezou HC, Tsakris A. Anaphylactic reactions to mRNA COVID-19 vaccines: a name for additional examine. Vaccine. 2021;39:2605–7.
Noor R. Developmental standing of the potential vaccines for the mitigation of the COVID-19 pandemic and a give attention to the effectiveness of the Pfizer-BioNTech and moderna mRNA vaccines. Curr Clin Microbiol Rep. 2021;8:1–8.
Folegatti PM, Ewer KJ, Aley PK, et al. Security and immunogenicity of the ChAdOx1 nCoV-19 vaccine in opposition to SARS-CoV-2: a preliminary report of a section 1/2, single-blind, randomised managed trial. Lancet. 2020;396:467–78.
Kang YF, Solar C, Zhuang Z, et al. Speedy growth of SARS-CoV-2 spike protein receptor-binding area self-assembled nanoparticle vaccine candidates. ACS Nano. 2021;15:2738–52.
McKay PF, Hu Okay, Blakney AK, et al. Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces excessive neutralizing antibody titers in mice. Nat Commun. 2020;11:3523.
Zeng C, Hou X, Yan J, et al. Leveraging mRNA sequences and nanoparticles to ship SARS-CoV-2 antigens in vivo. Adv Mater. 2020;32:2004452.
Al-Halifa S, Gauthier L, Arpin D, Bourgault S, Archambault D. Nanoparticle-based vaccines in opposition to respiratory viruses. Entrance Immunol. 2019;10:22.
Zhu M, Wang R, Nie G. Functions of nanomaterials as vaccine adjuvants. Hum Vaccines Immunother. 2014;10:2761–74.
He Y, Hara H, Núñez G. Mechanism and regulation of NLRP3 inflammasome activation. Tendencies Biochem Sci. 2016;41:1012–21.
Scharf B, Clement CC, Wu XX, Morozova Okay, Zanolini D, Follenzi A, et al. Annexin A2 binds to endosomes following organelle destabilization by particulate put on particles. Nat Commun. 2012;3:1–10.
Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T, et al. The NALP3 inflammasome is concerned within the innate immune response to amyloid-β. Nat Immunol. 2008;9:857–65.
Vicente S, Diaz-Freitas B, Peleteiro M, Sanchez A, Pascual DW, Gonzalez-Fernandez A, et al. A polymer/oil primarily based nanovaccine as a single-dose immunization strategy. PLoS ONE. 2013;8: e62500.
Sawaengsak C, Mori Y, Yamanishi Okay, Mitrevej A, Sinchaipanid N. Chitosan nanoparticle encapsulated hemagglutinin-split influenza virus mucosal vaccine. AAPS PharmSciTech. 2014;15:317–25.
Lopes AM, Apolinário AC, Valenzuela-Oses JK, Costa JS, Pessoa A, Barbosa LR. Nanostructures for protein drug supply. Biomater Sci. 2016;4:205–18.
Degobert G, Aydin D. Lyophilization of nanocapsules: instability sources, formulation and course of parameters. Pharmaceutics. 2021;13:1112.
Schneider CS, Xu Q, Boylan NJ, Chisholm J, Tang BC, Schuster BS, et al. Nanoparticles that don’t adhere to mucus present uniform and long-lasting drug supply to airways following inhalation. Sci Adv. 2017;3: e1601556.
Kang H, Yan M, Yu Q, Yang Q. Traits of nasal-associated lymphoid tissue (NALT) and nasal absorption capability in hen. PLoS ONE. 2013;8: e84097.
Marasini N, Skwarczynski M, Toth I. Intranasal supply of nanoparticle-based vaccines. Ther Deliv. 2017;8:151–67.
Gomes AC, Mohsen M, Bachmann MF. Harnessing nanoparticles for immunomodulation and vaccines. Vaccines. 2017;5:6.
Dowling DJ, Scott EA, Scheid A, Bergelson I, Joshi S, Pietrasanta C, et al. Toll-like receptor 8 agonist nanoparticles mimic immunomodulating results of the reside BCG vaccine and improve neonatal innate and adaptive immune responses. J Allergy Clin Immunol. 2017;140:1339–50.
Raghuwanshi D, Mishra V, Suresh MR, Kaur Okay. A easy strategy for enhanced immune response utilizing engineered dendritic cell focused nanoparticles. Vaccine. 2012;30:7292–9.
Lynn GM, Laga R, Darrah PA, Ishizuka AS, Balaci AJ, Dulcey AE, et al. In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that improve vaccine immunogenicity. Nat Biotechnol. 2015;33:1201–10.
Rauf A, Abu-Izneid T, Khalil AA, Hafeez N, Olatunde A, Rahman M, et al. Nanoparticles in medical trials of COVID-19: an replace. Int J Surg. 2022;104: 106818.
Anselmo AC, Mitragotri S. Nanoparticles within the clinic: an replace put up COVID-19 vaccines. Bioeng Transl Med. 2021;6: e10246.
Rosenthal PJ. The significance of diagnostic testing throughout a viral pandemic: early classes from novel coronavirus illness (CoVID-19). Am J Trop Med Hyg. 2020;102:915.
Pokhrel P, Hu C, Mao H. Detecting the coronavirus (COVID-19). ACS Sens. 2020;5:2283–96.
Mokhtarzadeh A, Eivazzadeh-Keihan R, Pashazadeh P, Hejazi M, Gharaatifar N, Hasanzadeh M, et al. Nanomaterial-based biosensors for detection of pathogenic virus. TrAC Tendencies Anal Chem. 2017;97:445–57.
Yuan X, Yang C, He Q, Chen J, Yu D, Li J, et al. Present and perspective diagnostic methods for COVID-19. ACS Infect Dis. 2020;6:1998–2016.
Shetti NP, Mishra A, Bukkitgar SD, Basu S, Narang J, Raghava Reddy Okay, et al. Typical and nanotechnology-based sensing strategies for SARS coronavirus (2019-nCoV). ACS Appl Bio Mater. 2021;4:1178–90.
Ahmed SR, Kang SW, Oh S, Lee J, Neethirajan S. Chiral zirconium quantum dots: a brand new class of nanocrystals for optical detection of coronavirus. Heliyon. 2018;4: e00766.
Luo F, Lengthy C, Wu Z, Xiong H, Chen M, Zhang X, et al. Purposeful silica nanospheres for delicate detection of H9N2 avian influenza virus primarily based on immunomagnetic separation. Sens Actuators B Chem. 2020;310: 127831.
Zheng L, Wei J, Lv X, Bi Y, Wu P, Zhang Z, et al. Detection and differentiation of influenza viruses with glycan-functionalized gold nanoparticles. Biosens Bioelectron. 2017;91:46–52.
Luo Z, Chen L, Liang C, Wei Q, Chen Y, Wang J. Porous carbon movies adorned with silver nanoparticles as a delicate SERS substrate, and their software to virus identification. Microchim Acta. 2017;184:3505–11.
Tran TL, Nguyen TT, Tran TTH, Tran QT, Mai AT. Detection of influenza A virus utilizing carbon nanotubes area impact transistor primarily based DNA sensor. Phys E Low-dimens Syst Nanostruct. 2017;93:83–6.
Zehbe I, Hacker GW, Su H, Hauser-Kronberger C, Hainfeld JF, Tubbs R. Delicate in situ hybridization with catalyzed reporter deposition, streptavidin-nanogold, and silver acetate autometallography: detection of single-copy human papillomavirus. Am J Pathol. 1997;150:1553.
Elahi N, Kamali M, Baghersad MH. Latest biomedical functions of gold nanoparticles: a evaluate. Talanta. 2018;184:537–56.
Amendola V, Pilot R, Frasconi M, Maragò OM, Iatì MA. Floor plasmon resonance in gold nanoparticles: a evaluate. J Phys Condens Matter. 2017;29: 203002.
Moitra P, Alafeef M, Dighe Okay, Frieman MB, Pan D. Selective naked-eye detection of SARS-CoV-2 mediated by N gene focused antisense oligonucleotide capped plasmonic nanoparticles. ACS Nano. 2020;14:7617–27. https://doi.org/10.1021/acsnano.0c03822.
Alfassam HA, Nassar MS, Almusaynid MM, Khalifah BA, Alshahrani AS, Almughem FA, et al. Growth of a colorimetric device for SARS-CoV-2 and different respiratory viruses detection utilizing sialic acid fabricated gold nanoparticles. Pharmaceutics. 2021;13:502.
Bagheri M, Validi M, Gholipour A, Makvandi P, Sharifi E. Chitosan nanofiber biocomposites for potential wound therapeutic functions: antioxidant exercise with synergic antibacterial impact. Bioeng Transl Med. 2022;7: e10254. https://doi.org/10.1002/btm2.10254.
Pilaquinga F, Morey J, Torres M, Seqqat R, Pina MDLN. Silver nanoparticles as a possible remedy in opposition to SARS-CoV-2: a evaluate. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021;13: e1707.
Yang G, Nanda J, Wang B, Chen G, Hallinan DT Jr. Self-assembly of enormous gold nanoparticles for surface-enhanced Raman spectroscopy. ACS Appl Mater Interfaces. 2017;9:13457–70.
Zong C, Xu M, Xu L-J, Wei T, Ma X, Zheng X-S, et al. Floor-enhanced Raman spectroscopy for bioanalysis: reliability and challenges. Chem Rev. 2018;118:4946–80.
Kozel TR, Burnham-Marusich AR. Level-of-care testing for infectious ailments: previous, current, and future. J Clin Microbiol. 2017;55:2313–20.
Li Z, Yi Y, Luo X, Xiong N, Liu Y, Li S, et al. Growth and medical software of a fast IgM-IgG mixed antibody check for SARS-CoV-2 an infection prognosis. J Med Virol. 2020;92:1518–24.
Huang C, Wen T, Shi F-J, Zeng X-Y, Jiao Y-J. Speedy detection of IgM antibodies in opposition to the SARS-CoV-2 virus through colloidal gold nanoparticle-based lateral-flow assay. ACS Omega. 2020;5:12550–6.
Li D, Chen H, Gao X, Mei X, Yang L. Growth of basic strategies for detection of virus by engineering fluorescent silver nanoclusters. ACS Sens. 2021;6:613–27.
Yang J, Jin R. New advances in atomically exact silver nanoclusters. ACS Mater Lett. 2019;1:482–9.
Cao Q, Teng Y, Yang X, Wang J, Wang E. A label-free fluorescent molecular beacon primarily based on DNA-Ag nanoclusters for the development of versatile biosensors. Biosens Bioelectron. 2015;74:318–21.
Chatterjee Okay, Sarkar S, Rao KJ, Paria S. Core/shell nanoparticles in biomedical functions. Adv Colloid Interface Sci. 2014;209:8–39.
Karn-Orachai Okay, Sakamoto Okay, Laocharoensuk R, Bamrungsap S, Songsivilai S, Dharakul T, et al. Extrinsic surface-enhanced Raman scattering detection of influenza A virus enhanced by two-dimensional gold@ silver core–shell nanoparticle arrays. RSC Adv. 2016;6:97791–9.
Smyrlaki I, Ekman M, Lentini A, de Sousa NR, Papanicolaou N, Vondracek M, et al. Large and fast COVID-19 testing is possible by extraction-free SARS-CoV-2 RT-PCR. Nat Commun. 2020;11:1–12.
Mirza S, Ahmad MS, Shah MIA, Ateeq M. Magnetic nanoparticles: drug supply and bioimaging functions. In: Steel nanoparticles for drug supply and diagnostic functions. Amsterdam: Elsevier; 2019. p. 189–213.
Wu Okay, Su D, Liu J, Saha R, Wang J-P. Magnetic nanoparticles in nanomedicine: a evaluate of current advances. Nanotechnology. 2019;30: 502003.
Zhao Z, Cui H, Music W, Ru X, Zhou W, Yu X. A easy magnetic nanoparticles-based viral RNA extraction methodology for environment friendly detection of SARS-CoV-2. bioRxiv. 2020. https://doi.org/10.1101/2020.02.22.961268.
Shen Q, Liang H, Tian J, Zhou C, Gao A, Wang D, et al. A magnetic nanoparticle labeled immunochromatography equipment for SARS-CoV-2 an infection prognosis. Nano Biomed Eng. 2020;12:325–30.
Wu Okay, Liu J, Saha R, Su D, Krishna VD, Cheeran MC-J, et al. Magnetic particle spectroscopy for detection of influenza A virus subtype H1N1. ACS Appl Mater Interfaces. 2020;12:13686–97.
Sharifi E, Azami M, Kajbafzadeh A-M, Moztarzadeh F, Faridi-Majidi R, Shamousi A, et al. Preparation of a biomimetic composite scaffold from gelatin/collagen and bioactive glass fibers for bone tissue engineering. Mater Sci Eng C. 2016;59:533–41.
Jagaran Okay, Singh M. Nanomedicine for covid-19: potential of copper nanoparticles. Biointerface Res Appl Chem. 2020;11:10716–28.
Jha A, Jarvis H, Fraser C, Openshaw P. Respiratory syncytial virus. In: SARS, MERS different viral lung Infect. Lausanne: European Respiratory Society; 2016.
Valdez J, Bawage S, Gomez I, Singh SR. Facile and fast detection of respiratory syncytial virus utilizing metallic nanoparticles. J Nanobiotechnol. 2016;14:1–12.
Jeelani PG, Mulay P, Venkat R, Ramalingam C. Multifaceted software of silica nanoparticles. A evaluate. SILICON. 2020;12:1337–54.
Chaibun T, Puenpa J, Ngamdee T, Boonapatcharoen N, Athamanolap P, O’Mullane AP, et al. Speedy electrochemical detection of coronavirus SARS-CoV-2. Nat Commun. 2021;12:1–10.
Wasfi A, Awwad F, Gelovani JG, Qamhieh N, Ayesh AI. COVID-19 detection through silicon nanowire field-effect transistor: setup and modeling of its perform. Nanomaterials. 2022;12:2638.
Bamrungsap S, Apiwat C, Chantima W, Dharakul T, Wiriyachaiporn N. Speedy and delicate lateral move immunoassay for influenza antigen utilizing fluorescently-doped silica nanoparticles. Microchim Acta. 2014;181:223–30.
Yang D, Li X, Meng D, Yang Y. Carbon quantum dots-modified ferrofluid for dispersive solid-phase extraction of phenolic compounds in water and milk samples. J Mol Liq. 2018;261:155–61.
Bhamore JR, Jha S, Singhal RK, Park TJ, Kailasa SK. Facile inexperienced synthesis of carbon dots from Pyrus pyrifolia fruit for assaying of Al3+ ion through chelation enhanced fluorescence mechanism. J Mol Liq. 2018;264:9–16.
Pourreza N, Ghomi M. Inexperienced synthesized carbon quantum dots from Prosopis juliflora leaves as a twin off-on fluorescence probe for sensing mercury (II) and chemet drug. Mater Sci Eng C. 2019;98:887–96.
Li H, Kang Z, Liu Y, Lee S-T. Carbon nanodots: synthesis, properties and functions. J Mater Chem. 2012;22:24230–53.
Baker SN, Baker GA. Luminescent carbon nanodots: emergent nanolights. Angew Chemie Int Ed. 2010;49:6726–44.
Tuerhong M, Yang XU, Xue-Bo YIN. Evaluation on carbon dots and their functions. Chin J Anal Chem. 2017;45:139–50.
Liang X, Li N, Zhang R, Yin P, Zhang C, Yang N, et al. Carbon-based SERS biosensor: from substrate design to sensing and bioapplication. NPG Asia Mater. 2021;13:1–36.
Tian J, Zhao H, Liu M, Chen Y, Quan X. Detection of influenza A virus primarily based on fluorescence resonance vitality switch from quantum dots to carbon nanotubes. Anal Chim Acta. 2012;723:83–7.
Banerjee AN. Graphene and its derivatives as biomedical supplies: future prospects and challenges. Interface Focus. 2018;8:20170056.
Eigler S, Hirsch A. Chemistry with graphene and graphene oxide—challenges for artificial chemists. Angew Chemie Int Ed. 2014;53:7720–38.
Zheng P, Wu N. Fluorescence and sensing functions of graphene oxide and graphene quantum dots: a evaluate. Chem Asian J. 2017;12:2343–53.
Palmieri V, Papi M. Can graphene participate within the battle in opposition to COVID-19? Nano Right this moment. 2020;33: 100883.
Jeong S, Kim D-M, An S-Y, Kim DH, Kim D-E. Fluorometric detection of influenza viral RNA utilizing graphene oxide. Anal Biochem. 2018;561:66–9.
Gupta S, Murthy CN, Prabha CR. Latest advances in carbon nanotube primarily based electrochemical biosensors. Int J Biol Macromol. 2018;108:687–703.
Anzar N, Hasan R, Tyagi M, Yadav N, Narang J. Carbon nanotube—a evaluate on synthesis, properties and plethora of functions within the area of biomedical science. Sens Int. 2020;1: 100003.
Pinals RL, Ledesma F, Yang D, Navarro N, Jeong S, Pak JE, et al. Speedy SARS-CoV-2 spike protein detection by carbon nanotube-based near-infrared nanosensors. Nano Lett. 2021;21:2272–80.
Strasfeld L, Chou S. Antiviral drug resistance: mechanisms and medical implications. Infect Dis Clin. 2010;24:809–33.
Chaudhuri A, Kennedy PGE. Prognosis and remedy of viral encephalitis. Postgrad Med J. 2002;78:575–83.
Zhu J-D, Meng W, Wang X-J, Wang H-CR. Broad-spectrum antiviral brokers. Entrance Microbiol. 2015;6:517.
Zafar H, Raza F, Yousefiasl S. T-cell membrane-functionalized nanosystems for viral infectious ailments. Mater Chem Horiz. 2023;2:41–8.
Chakravarty M, Vora A. Nanotechnology-based antiviral therapeutics. Drug Deliv Transl Res. 2020;11:1–40.
Łoczechin A, Séron Okay, Barras A, Giovanelli E, Belouzard S, Chen YT, et al. Purposeful carbon quantum dots as medical countermeasures to human coronavirus. ACS Appl Mater Interfaces. 2019;11:42964–74.
Sarkar PK, Das Mukhopadhyay C. Ayurvedic metallic nanoparticles may very well be novel antiviral brokers in opposition to SARS-CoV-2. Int Nano Lett. 2021;11:1–7.
Elechiguerra JL, Burt JL, Morones JR, Camacho-Bragado A, Gao X, Lara HH, et al. Interplay of silver nanoparticles with HIV-1. J Nanobiotechnol. 2005;3:1–10.
Morris D, Ansar M, Speshock J, Ivanciuc T, Qu Y, Casola A, et al. Antiviral and immunomodulatory exercise of silver nanoparticles in experimental RSV an infection. Viruses. 2019;11:732.
Park S, Ko Y-S, Lee SJ, Lee C, Woo Okay, Ko G. Inactivation of influenza A virus through publicity to silver nanoparticle-decorated silica hybrid composites. Environ Sci Pollut Res. 2018;25:27021–30.
Ravindran A, Chandrasekaran N, Mukherjee A. Research on differential conduct of silver nanoparticles in the direction of thiol containing amino acids. Curr Nanosci. 2012;8:141–9.
Villeret B, Dieu A, Straube M, Solhonne B, Miklavc P, Hamadi S, et al. Silver nanoparticles impair retinoic acid-inducible gene I-mediated mitochondrial antiviral immunity by blocking the autophagic flux in lung epithelial cells. ACS Nano. 2018;12:1188–202.
De Gusseme B, Sintubin L, Baert L, Thibo E, Hennebel T, Vermeulen G, et al. Biogenic silver for disinfection of water contaminated with viruses. Appl Environ Microbiol. 2010;76:1082–7.
Du T, Liang J, Dong N, Lu J, Fu Y, Fang L, et al. Glutathione-capped Ag2S nanoclusters inhibit coronavirus proliferation by means of blockage of viral RNA synthesis and budding. ACS Appl Mater Interfaces. 2018;10:4369–78.
Yang XX, Li CM, Huang CZ. Curcumin modified silver nanoparticles for extremely environment friendly inhibition of respiratory syncytial virus an infection. Nanoscale. 2016;8:3040–8.
Bar-Ilan O, Albrecht RM, Fako VE, Furgeson DY. Toxicity assessments of multisized gold and silver nanoparticles in zebrafish embryos. Small. 2009;5:1897–910.
Chen S, Hao X, Liang X, Zhang Q, Zhang C, Zhou G, et al. Inorganic nanomaterials as carriers for drug supply. J Biomed Nanotechnol. 2016;12:1–27.
Huang X, Li M, Xu Y, Zhang J, Meng X, An X, et al. Novel gold nanorod-based HR1 peptide inhibitor for Center East respiratory syndrome coronavirus. ACS Appl Mater Interfaces. 2019;11:19799–807.
Kim J, Yeom M, Lee T, Kim H-O, Na W, Kang A, et al. Porous gold nanoparticles for attenuating infectivity of influenza A virus. J Nanobiotechnol. 2020;18:1–11.
Osminkina LA, Timoshenko VY, Shilovsky IP, Kornilaeva GV, Shevchenko SN, Gongalsky MB, et al. Porous silicon nanoparticles as scavengers of hazardous viruses. J Nanopart Res. 2014;16:1–10.
Zhao M, Wu W, Su B. pH-controlled drug launch by diffusion by means of silica nanochannel membranes. ACS Appl Mater Interfaces. 2018;10:33986–92.
Li Y, Lin Z, Gong G, Guo M, Xu T, Wang C, et al. Inhibition of H1N1 influenza virus-induced apoptosis by selenium nanoparticles functionalized with arbidol by means of ROS-mediated signaling pathways. J Mater Chem B. 2019;7:4252–62.
Li Y, Lin Z, Guo M, Xia Y, Zhao M, Wang C, et al. Inhibitory exercise of selenium nanoparticles functionalized with oseltamivir on H1N1 influenza virus. Int J Nanomed. 2017;12:5733.
Kumar R, Nayak M, Sahoo GC, Pandey Okay, Sarkar MC, Ansari Y, et al. Iron oxide nanoparticles primarily based antiviral exercise of H1N1 influenza A virus. J Infect Chemother. 2019;25:325–9.
Abo-Zeid Y, Ismail NSM, McLean GR, Hamdy NM. A molecular docking examine repurposes FDA authorised iron oxide nanoparticles to deal with and management COVID-19 an infection. Eur J Pharm Sci. 2020;153: 105465.
Huo C, Xiao J, Xiao Okay, Zou S, Wang M, Qi P, et al. Pre-treatment with zirconia nanoparticles reduces irritation induced by the pathogenic H5N1 influenza virus. Int J Nanomed. 2020;15:661–74.
Tu Z, Guday G, Adeli M, Haag R. Multivalent interactions between 2D nanomaterials and biointerfaces. Adv Mater. 2018;30:1–27.
Ye S, Shao Okay, Li Z, Guo N, Zuo Y, Li Q, et al. Antiviral exercise of graphene oxide: how sharp edged construction and cost matter. ACS Appl Mater Interfaces. 2015;7:21571–9.
Music Z, Wang X, Zhu G, Nian Q, Zhou H, Yang D, et al. Virus seize and destruction by label-free graphene oxide for detection and disinfection functions. Small. 2015;11:1171–6.
Chen Y-N, Hsueh Y-H, Hsieh C-T, Tzou D-Y, Chang P-L. Antiviral exercise of graphene–silver nanocomposites in opposition to non-enveloped and enveloped viruses. Int J Environ Res Public Well being. 2016;13:430.
Yang XX, Li CM, Li YF, Wang J, Huang CZ. Synergistic antiviral impact of curcumin functionalized graphene oxide in opposition to respiratory syncytial virus an infection. Nanoscale. 2017;9:16086–92.
Donskyi IS, Azab W, Cuellar-Camacho JL, Guday G, Lippitz A, Unger WES, et al. Functionalized nanographene sheets with excessive antiviral exercise by means of synergistic electrostatic and hydrophobic interactions. Nanoscale. 2019;11:15804–9.
Lin LC, Huang C, Yao B, Lin J, Agrawal A, Algaissi A, et al. Viromimetic STING agonist-loaded hole polymeric nanoparticles for secure and efficient vaccination in opposition to Center East respiratory syndrome coronavirus. Adv Funct Mater. 2019;29:1807616.
Milewska A, Kaminski Okay, Ciejka J, Kosowicz Okay, Zeglen S, Wojarski J, et al. HTCC: broad vary inhibitor of coronavirus entry. PLoS ONE. 2016;11: e0156552.
Aghamiri S, Talaei S, Ghavidel AA, Zandsalimi F, Masoumi S, Hafshejani NH, et al. Nanoparticles-mediated CRISPR/Cas9 supply: current advances in most cancers remedy. J Drug Deliv Sci Technol. 2020;56: 101533.
Lee Okay, Conboy M, Park HM, Jiang F, Kim HJ, Dewitt MA, et al. Nanoparticle supply of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA restore. Nat Biomed Eng. 2017;1:889–901.
Zheng Z, Li Z, Xu C, Guo B, Guo P. Folate-displaying exosome mediated cytosolic supply of siRNA avoiding endosome trapping. J Management Launch. 2019;311–312:43–9.
Bitko V, Musiyenko A, Shulyayeva O, Barik S. Inhibition of respiratory viruses by nasally administered siRNA. Nat Med. 2005;11(1):50–5.
Wu C-J, Huang H-W, Liu C-Y, Hong C-F, Chan Y-L. Inhibition of SARS-CoV replication by siRNA. Antivir Res. 2005;65:45–8.
Yeung M-L, Yao Y, Jia L, Chan JFW, Chan Okay-H, Cheung Okay-F, et al. MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2. Nat Microbiol. 2016;1:1–8.
Gu SH, Yu CH, Music Y, Kim NY, Sim E, Choi JY, et al. A Small interfering RNA lead focusing on RNA-dependent RNA-polymerase successfully inhibit the SARS-CoV-2 an infection in Golden Syrian hamster and Rhesus macaque. bioRxiv. 2020. https://doi.org/10.1101/2020.07.07.190967.
Teng M, Yao Y, Nair V, Luo J. Newest advances of virology analysis utilizing CRISPR/Cas9-based gene-editing know-how and its software to vaccine growth. Viruses. 2021;13:779.
Moses C, Kaur P. Functions of CRISPR methods in respiratory well being: coming into a brand new ‘pink pen’ period in genome modifying. Respirology. 2019;24:628–37.
Cox DBT, Gootenberg JS, Abudayyeh OO, Franklin B, Kellner MJ, Joung J, et al. RNA modifying with CRISPR-Cas13. Science (80-). 2017;358:1019–27.
Li L, He Z-Y, Wei X-W, Gao G-P, Wei Y-Q. Challenges in CRISPR/CAS9 supply: potential roles of nonviral vectors. Hum Gene Ther. 2015;26:452–62.
Ho W, Zhang X-Q, Xu X. Biomaterials in siRNA supply: a complete evaluate. Adv Healthc Mater. 2016;5:2715–31.
Khademhosseini A, Peppas NA. Micro-and nanoengineering of biomaterials for healthcare functions. 2013. https://onlinelibrary.wiley.com/doi/full/10.1002/adhm.201200444
Artiga Á, Serrano-Sevilla I, De Matteis L, Mitchell SG, Jesús M. Present standing and future views of gold nanoparticle vectors for siRNA supply. J Mater Chem B. 2019;7:876–96.
Chen F, Alphonse M, Liu Q. Methods for nonviral nanoparticle-based supply of CRISPR/Cas9 therapeutics. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020;12: e1609.
Liu J, Chang J, Jiang Y, Meng X, Solar T, Mao L, et al. Quick and environment friendly CRISPR/Cas9 genome modifying in vivo enabled by bioreducible lipid and messenger RNA nanoparticles. Adv Mater. 2019;31:1902575.
Deng H, Huang W, Zhang Z. Nanotechnology primarily based CRISPR/Cas9 system supply for genome modifying: progress and prospect. Nano Res. 2019;12:2437–50.
Mahmoodi Chalbatani G, Dana H, Gharagouzloo E, Grijalvo S, Eritja R, Logsdon CD, et al. Small interfering RNAs (siRNAs) in most cancers remedy: a nano-based strategy. Int J Nanomed. 2019;14:3111–28.
Sohail MF, Hussain SZ, Saeed H, Javed I, Sarwar HS, Nadhman A, et al. Polymeric nanocapsules embedded with ultra-small silver nanoclusters for synergistic pharmacology and improved oral supply of Docetaxel. Sci Rep. 2018;8:1–11.
Chen C-Okay, Huang P-Okay, Regulation W-C, Chu C-H, Chen N-T, Lo L-W. Biodegradable polymers for gene-delivery functions. Int J Nanomed. 2020;15:2131.
Wang H-X, Music Z, Lao Y-H, Xu X, Gong J, Cheng D, et al. Nonviral gene modifying through CRISPR/Cas9 supply by membrane-disruptive and endosomolytic helical polypeptide. Proc Natl Acad Sci. 2018;115:4903–8.
Wang P, Zhang L, Xie Y, Wang N, Tang R, Zheng W, et al. Genome modifying for most cancers remedy: supply of Cas9 protein/sgRNA plasmid through a gold nanocluster/lipid core–shell nanocarrier. Adv Sci. 2017;4:1700175.
Blanchard EL, Vanover D, Bawage SS, Tiwari PM, Rotolo L, Beyersdorf J, et al. Therapy of influenza and SARS-CoV-2 infections through mRNA-encoded Cas13a in rodents. Nat Biotechnol. 2021;39:717–26.
Dabbagh A, Abu Kasim NH, Yeong CH, Wong TW, Abdul RN. Vital parameters for particle-based pulmonary supply of chemotherapeutics. J Aerosol Med Pulm Drug Deliv. 2018;31:139–54.
Thanki Okay, van Eetvelde D, Geyer A, Fraire J, Hendrix R, Van Eygen H, et al. Mechanistic profiling of the discharge kinetics of siRNA from lipidoid-polymer hybrid nanoparticles in vitro and in vivo after pulmonary administration. J Management Launch. 2019;310:82–93.
Zhang W, Yang H, Kong X, Mohapatra S, San Juan-Vergara H, Hellermann G, et al. Erratum: Inhibition of respiratory syncytial virus an infection with intranasal siRNA nanoparticles focusing on the viral NS1 gene (Nature Medication 2005;11:56–62). Nat Med. 2005;11(2):233.
Idris A, Davis A, Supramaniam A, Acharya D, Kelly G, Tayyar Y, et al. A SARS-CoV-2 focused siRNA-nanoparticle remedy for COVID-19. Mol Ther. 2021;29(7):2219–26.
Totura AL, Baric RS. SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon. Curr Opin Virol. 2012;2:264–75.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Medical options of sufferers contaminated with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.
Olbei M, Hautefort I, Modos D, Treveil A, Poletti M, Gul L, et al. SARS-CoV-2 causes a distinct cytokine response in comparison with different cytokine storm-causing respiratory viruses in severely unwell sufferers. Entrance Immunol. 2021;12:381.
Ryabkova VA, Churilov LP, Shoenfeld Y. Influenza an infection, SARS, MERS and COVID-19: cytokine storm—the frequent denominator and the teachings to be realized. Clin Immunol. 2020;223: 108652.
Giménez E, Albert E, Torres I, Remigia MJ, Alcaraz MJ, Galindo MJ, et al. SARS-CoV-2-reactive interferon-γ-producing CD8+ T cells in sufferers hospitalized with coronavirus illness 2019. J Med Virol. 2021;93:375–82.
Davidson S, Maini MK, Wack A. Illness-promoting results of kind I interferons in viral, bacterial, and coinfections. J Interf Cytokine Res. 2015;35:252–64.
Lei X, Dong X, Ma R, Wang W, Xiao X, Tian Z, et al. Activation and evasion of kind I interferon responses by SARS-CoV-2. Nat Commun. 2020;11:1–12.
Zhang Q, Wang Y, Qi C, Shen L, Li J. Medical trial evaluation of 2019-nCoV remedy registered in China. J Med Virol. 2020;92:540–5.
Levine MM. Monoclonal antibody remedy for Ebola virus illness. Mass Medical Soc. 2019;381(24):2365–6.
Di Gioacchino M, Petrarca C, Gatta A, Scarano G, Farinelli A, Della Valle L, et al. Nanoparticle-based immunotherapy: state-of-the-art and future views. Knowledgeable Rev Clin Immunol. 2020;16:513–25.
Shi Y, Lammers T. Combining nanomedicine and immunotherapy. Acc Chem Res. 2019;52:1543–54.
Irvine DJ, Hanson MC, Rakhra Okay, Tokatlian T. Artificial nanoparticles for vaccines and immunotherapy. Chem Rev. 2015;115:11109–46.
Dykman LA, Khlebtsov NG. Gold nanoparticles in biology and medication: current advances and prospects. Acta Nat (aнглoязычнaя вepcия). 2011;3:34–55.
Yang Z, Ma Y, Zhao H, Yuan Y, Kim BYS. Nanotechnology platforms for most cancers immunotherapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020;12: e1590.
Lee M-Y, Yang J-A, Jung HS, Beack S, Choi JE, Hur W, et al. Hyaluronic acid–gold nanoparticle/interferon α complicated for focused remedy of hepatitis C virus an infection. ACS Nano. 2012;6:9522–31.
Wilson JT, Keller S, Manganiello MJ, Cheng C, Lee C-C, Opara C, et al. pH-Responsive nanoparticle vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides. ACS Nano. 2013;7:3912–25.
Sayour EJ, De Leon G, Pham C, Grippin A, Kemeny H, Chua J, et al. Systemic activation of antigen-presenting cells through RNA-loaded nanoparticles. Oncoimmunology. 2017;6: e1256527.
Roth GA, Saouaf OM, Smith AAA, Gale EC, Hernández MA, Idoyaga J, et al. Extended codelivery of hemagglutinin and a TLR7/8 agonist in a supramolecular polymer–nanoparticle hydrogel enhances efficiency and breadth of influenza vaccination. ACS Biomater Sci Eng. 2021;7:1889–99.
Roma-Rodrigues C, Pombo I, Raposo L, Pedrosa P, Fernandes AR, Baptista PV. Nanotheranostics focusing on the tumor microenvironment. Entrance Bioeng Biotechnol. 2019;7:197.
Madanayake NH, Rienzie R, Adassooriya NM. Nanoparticles in nanotheranostics functions. In: Nanotheranostics: functions and limitations. Cham: Springer; 2019. p. 19–40.
Kushnir N, Streatfield SJ, Yusibov V. Virus-like particles as a extremely environment friendly vaccine platform: range of targets and manufacturing methods and advances in medical growth. Vaccine. 2012;31:58–83.
Chung YH, Cai H, Steinmetz NF. Viral nanoparticles for drug supply, imaging, immunotherapy, and theranostic functions. Adv Drug Deliv Rev. 2020;156:214–35.
Lam P, Steinmetz NF. Supply of siRNA therapeutics utilizing cowpea chlorotic mottle virus-like particles. Biomater Sci. 2019;7:3138–42.
Lavatory LN, et al. Growth of Pink clover necrotic mosaic virus as a multifunctional nanoparticle. 2009. https://repository.lib.ncsu.edu/deal with/1840.16/4143
Kim H, Choi H, Bae Y, Kang S. Growth of target-tunable P22 VLP-based supply nanoplatforms utilizing bacterial superglue. Biotechnol Bioeng. 2019;116:2843–51.
Beatty PH, Lewis JD. Cowpea mosaic virus nanoparticles for most cancers imaging and remedy. Adv Drug Deliv Rev. 2019;145:130–44.
Lee Y-T, Ko E-J, Lee Y, Kim Okay-H, Kim M-C, Lee Y-N, et al. Intranasal vaccination with M2e5x virus-like particles induces humoral and mobile immune responses conferring cross-protection in opposition to heterosubtypic influenza viruses. PLoS ONE. 2018;13: e0190868.
Schiller J, Lowy D. Explanations for the excessive efficiency of HPV prophylactic vaccines. Vaccine. 2018;36:4768–73.
Mohsen MO, Zha L, Cabral-Miranda G, Bachmann MF. Main findings and up to date advances in virus-like particle (VLP)-based vaccines. In: Seminars in immunology. London: Educational Press; 2017. p. 123–32.
Kanekiyo M, Wei C-J, Yassine HM, McTamney PM, Boyington JC, Whittle JRR, et al. Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies. Nature. 2013;499:102–6.
Kanekiyo M, Bu W, Joyce MG, Meng G, Whittle JRR, Baxa U, et al. Rational design of an Epstein–Barr virus vaccine focusing on the receptor-binding website. Cell. 2015;162:1090–100.
Wu Y, Narum DL, Fleury S, Jennings G, Yadava A. Particle-based platforms for malaria vaccines. Vaccine. 2015;33:7518–24.
Jeevanandam J, Pal Okay, Danquah MK. Virus-like nanoparticles as a novel supply device in gene remedy. Biochimie. 2019;157:38–47.
Liu S, Yang J, Jia H, Zhou H, Chen J, Guo T. Virus spike and membrane-lytic mimicking nanoparticles for prime cell binding and superior endosomal escape. ACS Appl Mater Interfaces. 2018;10:23630–7.
Shukla S, Steinmetz NF. Virus-based nanomaterials as positron emission tomography and magnetic resonance distinction brokers: from know-how growth to translational medication. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2015;7:708–21.
Chen Okay, Liu B, Yu B, Zhong W, Lu Y, Zhang J, et al. Advances within the growth of aptamer drug conjugates for focused drug supply. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017;9: e1438.
Zou X, Wu J, Gu J, Shen L, Mao L. Utility of aptamers in virus detection and antiviral remedy. Entrance Microbiol. 2019;10:1462.
Dzuvor C. Rethinking aptamers as nanotheranostic instruments for SARS-COV-2 and COVID-19 an infection. 2020.
Piyush R, Rajarshi Okay, Chatterjee A, Khan R, Ray S. Nucleic acid-based remedy for coronavirus illness 2019. Heliyon. 2020;6: e05007.
Jang KJ, Lee N-R, Yeo W-S, Jeong Y-J, Kim D-E. Isolation of inhibitory RNA aptamers in opposition to extreme acute respiratory syndrome (SARS) coronavirus NTPase/Helicase. Biochem Biophys Res Commun. 2008;366:738–44.
Shum KT, Tanner JA. Differential inhibitory actions and stabilisation of DNA aptamers in opposition to the SARS coronavirus helicase. ChemBioChem. 2008;9:3037.
Ivanov KA, Thiel V, Dobbe JC, Van Der Meer Y, Snijder EJ, Ziebuhr J. A number of enzymatic actions related to extreme acute respiratory syndrome coronavirus helicase. J Virol. 2004;78:5619–32.
Roh C, Jo SK. Quantitative and delicate detection of SARS coronavirus nucleocapsid protein utilizing quantum dots-conjugated RNA aptamer on chip. J Chem Technol Biotechnol. 2011;86:1475–9.
Ford J, Goldstein T, Trahan S, Neuwirth A, Tatoris Okay, Decker S. A 3D-printed nasopharyngeal swab for COVID-19 diagnostic testing. 3D Print Med. 2020;6:1–7.
Tai W, Zhang X, Drelich A, Shi J, Hsu JC, Luchsinger L, et al. A novel receptor-binding area (RBD)-based mRNA vaccine in opposition to SARS-CoV-2. Cell Res. 2020;30:932–5.
Chakhalian D, Shultz RB, Miles CE, Kohn J. Alternatives for biomaterials to handle the challenges of COVID-19. J Biomed Mater Res A. 2020;108:1974–90.
Kleinstreuer N, Holmes A. Harnessing the ability of microphysiological methods for COVID-19 analysis. Drug Discov Right this moment. 2021;26:2496–501.
Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, et al. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5:847–60.
Yayehrad AT, Siraj EA, Wondie GB, Alemie AA, Derseh MT, Ambaye AS. May nanotechnology assist to finish the battle in opposition to COVID-19? Evaluation of present findings, challenges and future views. Int J Nanomed. 2021;16:5713–43.
Melchor-Martínez EM, Torres Castillo NE, Macias-Garbett R, Lucero-Saucedo SL, Parra-Saldívar R, Sosa-Hernández JE. Fashionable world functions for nano-bio supplies: tissue engineering and COVID-19. Entrance Bioeng Biotechnol. 2021;9:1–16.
Carson D, Jiang Y, Woodrow KA. Tunable launch of multiclass anti-HIV medication which can be water-soluble and loaded at excessive drug content material in polyester blended electrospun fibers. Pharm Res. 2016;33:125–36.
Karagoz S, Kiremitler NB, Sarp G, Pekdemir S, Salem S, Goksu AG, et al. Antibacterial, antiviral, and self-cleaning mats with sensing capabilities primarily based on electrospun nanofibers adorned with ZnO nanorods and Ag nanoparticles for protecting clothes functions. ACS Appl Mater Interfaces. 2021;13:5678–90.
Castro-Mayorga JL, Randazzo W, Fabra MJ, Lagaron JM, Aznar R, Sánchez G. Antiviral properties of silver nanoparticles in opposition to norovirus surrogates and their efficacy in coated polyhydroxyalkanoates methods. LWT Meals Sci Technol. 2017;79:503–10.
